7-66152340-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_014478.5(CRCP):c.430G>A(p.Glu144Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000781 in 1,614,036 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_014478.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CRCP | NM_014478.5 | c.430G>A | p.Glu144Lys | missense_variant | 6/6 | ENST00000395326.8 | NP_055293.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CRCP | ENST00000395326.8 | c.430G>A | p.Glu144Lys | missense_variant | 6/6 | 1 | NM_014478.5 | ENSP00000378736.3 |
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 152182Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000108 AC: 27AN: 250998Hom.: 0 AF XY: 0.000118 AC XY: 16AN XY: 135684
GnomAD4 exome AF: 0.0000739 AC: 108AN: 1461738Hom.: 0 Cov.: 31 AF XY: 0.0000880 AC XY: 64AN XY: 727176
GnomAD4 genome AF: 0.000118 AC: 18AN: 152298Hom.: 0 Cov.: 31 AF XY: 0.000134 AC XY: 10AN XY: 74470
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 27, 2023 | The c.430G>A (p.E144K) alteration is located in exon 6 (coding exon 6) of the CRCP gene. This alteration results from a G to A substitution at nucleotide position 430, causing the glutamic acid (E) at amino acid position 144 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at